Zomig Nasal Spray

Zomig nasal spray is a prescription migraine treatment containing zolmitriptan, the same active ingredient as Zomig tablets and Zomig Rapimelt wafers, in a single-use, pre-metered spray device. Each device delivers one 5 mg spray into one nostril. It's used for acute treatment of migraine attacks with or without aura, and it works on the same receptors and through the same mechanism as the oral forms, just delivered differently to the bloodstream. Zomig nasal spray is manufactured by Grunenthal, and generic zolmitriptan nasal sprays are also available in the UK.

The active ingredient and overall effect on a migraine are the same in both forms. The differences are practical. The nasal spray works faster, with noticeable effect at around 15 minutes compared with 30 to 45 minutes for tablets. The spray also bypasses the stomach, which becomes important during migraine attacks where nausea and slow gastric emptying can make tablet absorption unreliable. The spray doesn't require swallowing, water, or sitting upright. The trade-offs are that the spray has an unpleasant taste (less severe than Imigran nasal spray, but still present), it costs more than tablets, and the device requires some hand coordination to use correctly. For someone whose migraines come on quickly and become severe within an hour, or whose attacks reliably bring vomiting, the spray is often the better choice. For more typical attacks with a longer build-up and milder nausea, tablets work fine and cost less. Many patients keep both forms at home and choose based on how a particular attack is unfolding.

Yes, meaningfully. Some of the medicine absorbs through the nasal lining for relatively quick entry into the bloodstream, while the rest drips down the back of the throat, is swallowed, and absorbs through the stomach in the usual way. The result is an onset of around 15 minutes, with peak effect at around 60 minutes. Zomig tablets typically start working at around 30 to 45 minutes with peak at about 2 hours. Zomig nasal spray sits in the same speed range as Imigran nasal spray (sumatriptan), and faster than any oral triptan formulation including Maxalt Melt (rizatriptan orodispersible wafer), which despite dissolving on the tongue is still absorbed via the stomach and has tablet-like onset. For most patients, the 15-minute onset of the nasal spray is fast enough to be useful, and the practical advantages over an injection (no needles, no preparation, easier to carry) make it the preferred fast-acting option for many.

Both are triptan nasal sprays used to treat acute migraines, and they share most of the practical characteristics: fast onset of around 15 minutes, the same general technique for use, the same broad side effect profile, and the same role in attacks where tablets are unreliable. The differences come down to the active ingredient and a few specific points. Zomig nasal spray uses zolmitriptan; Imigran uses sumatriptan. Zolmitriptan crosses the blood-brain barrier slightly more readily than sumatriptan, which some prescribers think makes it useful for migraines with prominent cognitive symptoms like brain fog or slowed thinking. The taste of Zomig nasal spray is reportedly less unpleasant than Imigran's, which is a small but meaningful comfort point. Imigran nasal spray is available in 10 mg and 20 mg strengths and is licensed for adolescents aged 12 to 17; Zomig nasal spray comes in 5 mg only and is licensed for adults only in the UK. Choosing between the two often comes down to which active ingredient a patient has responded to before, since some people respond better to one triptan than another.

Technique matters here, because the medicine works less well if it ends up running down the back of the throat rather than being absorbed by the nasal lining. The steps are: blow your nose gently to clear the nostril first, sit upright or with your head tilted very slightly forward, insert the nozzle into one nostril, close the other nostril with a finger, and press the plunger firmly while breathing in gently and steadily through your nose. Breathe out through your mouth, not your nose. Two common mistakes reduce effectiveness. The first is tilting the head back, which lets the medicine pool at the back of the throat where it isn't absorbed properly. The second is sniffing hard, which sucks the spray straight past the nasal mucosa and into the throat. The device is single-use: don't try to test it or prime it first, because the dose will be wasted. Each device contains one dose only.

The taste issue affects both nasal spray triptans, but Zomig is generally reported to be less unpleasant than Imigran. Sumatriptan in the Imigran spray has a notoriously bitter, almost chemical taste that catches new users by surprise. Zolmitriptan in the Zomig spray still has a noticeable taste when some of the dose drips down the back of the throat, but it's milder and shorter-lasting for most people. Across patient surveys and clinical experience, Zomig is the more tolerable of the two from a taste perspective, which can be a deciding factor for patients who've found Imigran spray hard to keep using. A few things help if the taste still bothers you: sipping water immediately after the spray, sucking a strong mint or boiled sweet, drinking a small amount of cold fruit juice, or eating something with a strong flavour if your stomach can tolerate it.

During a migraine attack, blood vessels in the head dilate, and a set of nerves around those vessels (the trigeminal nerves) release inflammatory chemicals that cause throbbing pain, nausea, sensitivity to light and sound, and the other classic migraine symptoms. Zolmitriptan works on receptors called 5-HT1B and 5-HT1D, which sit on those dilated vessels and on the nerve endings around them. Activating 5-HT1B receptors causes the dilated vessels to constrict back to their normal size. Activating 5-HT1D receptors stops the trigeminal nerves releasing the inflammatory chemicals that drive the pain. The result is that the migraine attack is interrupted at source rather than just having the pain dulled. Whether the zolmitriptan reaches the bloodstream through the nose or through the gut, the effect on receptors in the head is the same.

As early as possible after the headache phase begins. This is one of the most consistent findings in migraine research: triptans work much better when taken at the first sign of head pain than once a migraine is fully established. The nasal spray is particularly useful for early dosing because you don't need water or a swallow, so you can take it the moment you recognise an attack starting. Many people with regular migraines learn to recognise the earliest signals: a slight visual disturbance, a dull ache behind one eye, a strange stiffness in the neck, or a sense that "something's coming". Acting at that point can often abort the attack entirely. Waiting until you're vomiting and lying in a dark room reduces the chance of a good response significantly. If you have an aura before your headache, the usual advice is to wait until the headache itself starts before using the spray, because the aura phase doesn't respond to triptans and you don't want to use up a dose too early.

Zomig nasal spray comes in 5 mg only, and the standard dose is one spray of 5 mg into one nostril as soon as the headache begins. If the migraine comes back within 24 hours after an initial response, a second 5 mg spray can be used at least 2 hours after the first, up to a maximum of 10 mg in 24 hours. As with other triptans, a second dose isn't recommended if the first had no effect at all. Doses are adjusted in significant liver or kidney impairment, so tell your prescriber if either applies. The Zomig nasal spray is licensed for adults aged 18 and over only; for adolescents needing a fast-onset triptan, Imigran nasal spray 10 mg is the licensed alternative in the UK.

Most people tolerate Zomig nasal spray well. The "triptan sensations" common to this class of medicine include tingling, a feeling of warmth or coolness, mild flushing, and a sense of pressure or tightness that can be felt in the chest, throat, neck, jaw, or limbs. The chest tightness in particular tends to alarm people the first time they experience it, because the natural assumption is that it's something cardiac. In healthy people without heart disease this sensation isn't dangerous and reflects the medicine's action on blood vessels and smooth muscle. It usually settles within 30 minutes to an hour. Real cardiac chest pain can occur in someone with undiagnosed heart disease who uses a triptan, so the distinction matters. If the chest sensation is severe, prolonged, crushing, associated with breathlessness, or radiating down the arm, that needs urgent assessment rather than being assumed to be a "triptan sensation". Nasal-specific side effects include the unpleasant taste described above, mild nasal irritation, occasional nose bleeds, and throat discomfort. Other common general effects include drowsiness, dizziness, fatigue, dry mouth, and nausea.

A few interactions matter. Zomig nasal spray should not be used with monoamine oxidase inhibitor antidepressants (MAOIs) or within two weeks of stopping one, because the combination can cause dangerous rises in blood pressure and serotonin syndrome. It shouldn't be used with another triptan or with ergotamine-type migraine medicines on the same day, because the vasoconstriction effects can add up. SSRIs and SNRIs (sertraline, citalopram, venlafaxine, and others) carry a small theoretical risk of serotonin syndrome when combined with triptans, though in practice this is rare. The CYP1A2 inhibitors that affect zolmitriptan tablets matter for the nasal spray too, since both forms reach the bloodstream and are metabolised the same way: cimetidine, fluvoxamine, and ciprofloxacin can all significantly raise zolmitriptan blood levels and may require a dose reduction. On the heart problems question, zolmitriptan causes blood vessel constriction including in the coronary arteries that supply the heart muscle. The nasal spray is therefore contraindicated in the same situations as the tablet: established ischaemic heart disease, previous heart attack, coronary artery vasospasm (Prinzmetal's angina), uncontrolled high blood pressure, previous stroke, peripheral vascular disease, and Wolff-Parkinson-White syndrome. It's also used with caution in people who carry significant cardiovascular risk factors (older men, postmenopausal women, smokers, diabetes, raised cholesterol, family history of premature heart disease).

The safety data for zolmitriptan in pregnancy is more limited than for sumatriptan, which has been on the market longer and has a larger accumulated registry of pregnancy outcomes. What evidence exists doesn't show clear harm, but most clinicians prefer sumatriptan in pregnancy where a triptan is needed, because the safety database is so much bigger. If you're pregnant and considering Zomig nasal spray, the conversation is best had with your GP rather than self-managing. In breastfeeding, zolmitriptan passes into breast milk in small amounts, and the standard advice is to avoid breastfeeding for 24 hours after a dose. Some recent guidance takes a more relaxed view, but the 24-hour interval remains the conservative approach. Many women express and discard breast milk during that window to maintain supply.

The most important point about triptan frequency is the risk of medication overuse headache (MOH). This is a surprisingly common problem in which the body's response to frequent triptan use becomes paradoxical: the medicines that were helping start producing rebound headaches, which then prompt more medicine use, in a cycle that can become entrenched. The current threshold is taking a triptan on more than 10 days a month, on average, for three or more months. Above that level, the risk of MOH rises significantly. If you find yourself reaching for Zomig nasal spray 10 or more days a month, that's a strong signal that the conversation needs to shift from acute treatment to preventive treatment, a different category of medicine designed to reduce how often migraines happen in the first place. Treatment of medication overuse headache involves stopping the overused medicine for a period to allow the headache pattern to reset, often with specialist guidance.